Med Biogene (MBI.H) Financial Statements

4 Followers

Med Biogene Financial Overview

Med Biogene's market cap is currently C$345.16K. The company's EPS TTM is C$-0.002; its P/E ratio is -5.41; Med Biogene is scheduled to report earnings on August 28, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue
Gross Profit	-	-	-	-	-
Operating Income	$ -58.11K	$ -63.06K	$ -59.96K	$ -54.54K	$ -63.48K
EBITDA	$ -58.11K	$ -63.06K	$ -59.96K	$ -54.54K	$ -63.48K
Net Income	$ -58.11K	$ -63.06K	$ -59.96K	$ -54.54K	$ -63.48K
Balance Sheet
Cash & Short-Term Investments	$ ―	$ ―	$ ―	$ ―	$ ―
Total Assets	$ 2.31K	$ 3.00K	$ 10.79K	$ 81.83K	$ 13.15K
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -713.00	$ -407.00	$ -9.19K	$ -79.24K	$ -10.96K
Total Liabilities	$ 129.30K	$ 69.23K	$ 92.01K	$ 178.16K	$ 50.42K
Stockholders' Equity	$ ―	$ ―	$ ―	$ ―	$ ―
Cash Flow
Free Cash Flow
Operating Cash Flow	$ 2.94K	$ -8.32K	$ -145.12K	$ 72.80K	$ -151.46K
Investing Cash Flow
Financing Cash Flow

Med Biogene Earnings and Revenue History

Income Statement >

Med Biogene Debt to Assets

Balance Sheet >

Med Biogene Cash Flow

Cash Flow >

Med Biogene Forecast EPS vs Actual EPS

Earnings >